MedBeats
Breaking news and information from the CDC, FDA and medical journals.
Safety and Efficacy of Sodium Glucose Co-Transporter 2 Inhibitors Combined with Insulin in Adults with Type 1 Diabetes
RCT shows SGLT2 inhibitors did not induce hypoglycaemia, severe hypoglycaemia, cardiovascular events, bone fracture and all-cause mortality, but increased the risk of adverse events (AE),.
Read MoreNational Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys
By 2019, HCV-seronegative patients received the majority of kidneys transplanted from HCV-viremic donors. Widely used organ quality scores underestimated the quality of HCV-viremic kidneys based on 1-year allograft function.
Read MoreNeoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer
Study shows that the addition of NAC consisting of cisplatin and gemcitabine to standard CRT is not superior and is possibly inferior to CRT alone for the treatment of LACC.
Read MoreDual-Energy Computed Tomography Detection of Cardiovascular Monosodium Urate Deposits in Patients with Gout
Cardiovascular MSU deposits were detected by DECT significantly more often in patients with gout compared with controls and were associated with higher coronary calcium score.
Read MoreSerine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy
Elevated levels of atypical deoxysphingolipids, caused by variant SPTLC1 or SPTLC2 or by low serine levels, were risk factors for macular telangiectasia type 2, as well as for peripheral neuropathy
Read MoreStatement Alerting Patients and Health Care Professionals of NDMA Found in Samples of Ranitidine
NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.
Read MoreCognitive Impairment Across ALS Clinical Stages in a Population-Based Cohort
Findings suggest that ALS motor and cognitive components may worsen in parallel, and that cognitive impairment becomes more pronounced when bulbar function is involved.
Read MoreLupus Low Disease Activity State as a Treatment Endpoint for Systemic Lupus Erythematosus
LLDAS attainment is associated with significant protection against flare and damage accrual in SLE. These findings validate LLDAS as an endpoint for clinical studies in SLE.
Read MoreLow-Dose Interleukin-2 Therapy in Refractory Systemic Lupus Erythematosus
Low-dose IL-2 therapy is safe and well tolerated and selectively promotes the expansion of functional regulatory T cells in patients with moderate-to-severe systemic lupus erythematosus.
Read MoreVoluntary Wheel Running has Beneficial Effects in a Rat Model of CKD-Mineral Bone Disorder (CKD-MBD)
Voluntary wheel running resulted in multiple beneficial systemic effects in rats with CKD and improved their physical function. Studies examining exercise interventions in patients with CKD are warranted.
Read More